-
Description
-
Table of Contents
-
Table of Figures
PDF Download
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
The global Hepatitis B and C Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hepatitis B and C Diagnostics in various end use industries. The expanding demands from the Immunodiagnostics and Nucleic Acid Test (NAT), are propelling Hepatitis B and C Diagnostics market. Hepatitis B, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hepatitis C segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatitis B and C Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatitis B and C Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatitis B and C Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatitis B and C Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatitis B and C Diagnostics covered in this report include Roche Diagnostics, Abbott, Siemens, Qiagen, Abbott, bioMérieux, Cepheid, Chembio Diagnostics and DiaSorin, etc.
The global Hepatitis B and C Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott
Siemens
Qiagen
Abbott
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Global Hepatitis B and C Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis B and C Diagnostics market, Segment by Type:
Hepatitis B
Hepatitis C
Global Hepatitis B and C Diagnostics market, by Application
Immunodiagnostics
Nucleic Acid Test (NAT)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hepatitis B and C Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion 
1 Market Overview of Hepatitis B and C Diagnostics
1.1 Hepatitis B and C Diagnostics Market Overview
1.1.1 Hepatitis B and C Diagnostics Product Scope
1.1.2 Hepatitis B and C Diagnostics Market Status and Outlook
1.2 Global Hepatitis B and C Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hepatitis B and C Diagnostics Market Size by Region (2018-2029)
1.4 Global Hepatitis B and C Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Hepatitis B and C Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hepatitis B and C Diagnostics Market Size (2018-2029)
1.6.1 North America Hepatitis B and C Diagnostics Market Size (2018-2029)
1.6.2 Europe Hepatitis B and C Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size (2018-2029)
1.6.4 Latin America Hepatitis B and C Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Hepatitis B and C Diagnostics Market Size (2018-2029)
2 Hepatitis B and C Diagnostics Market by Type
2.1 Introduction
2.1.1 Hepatitis B
2.1.2 Hepatitis C
2.2 Global Hepatitis B and C Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hepatitis B and C Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hepatitis B and C Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hepatitis B and C Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hepatitis B and C Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hepatitis B and C Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hepatitis B and C Diagnostics Revenue Breakdown by Type (2018-2029)
3 Hepatitis B and C Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Immunodiagnostics
3.1.2 Nucleic Acid Test (NAT)
3.2 Global Hepatitis B and C Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hepatitis B and C Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hepatitis B and C Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hepatitis B and C Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hepatitis B and C Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hepatitis B and C Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hepatitis B and C Diagnostics Revenue Breakdown by Application (2018-2029)
4 Hepatitis B and C Diagnostics Competition Analysis by Players
4.1 Global Hepatitis B and C Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis B and C Diagnostics as of 2022)
4.3 Date of Key Players Enter into Hepatitis B and C Diagnostics Market
4.4 Global Top Players Hepatitis B and C Diagnostics Headquarters and Area Served
4.5 Key Players Hepatitis B and C Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Hepatitis B and C Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
5.1.4 Roche Diagnostics Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Hepatitis B and C Diagnostics Products, Services and Solutions
5.2.4 Abbott Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Siemens
5.3.1 Siemens Profile
5.3.2 Siemens Main Business
5.3.3 Siemens Hepatitis B and C Diagnostics Products, Services and Solutions
5.3.4 Siemens Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Qiagen Recent Developments
5.4 Qiagen
5.4.1 Qiagen Profile
5.4.2 Qiagen Main Business
5.4.3 Qiagen Hepatitis B and C Diagnostics Products, Services and Solutions
5.4.4 Qiagen Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Qiagen Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Hepatitis B and C Diagnostics Products, Services and Solutions
5.5.4 Abbott Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 bioMérieux
5.6.1 bioMérieux Profile
5.6.2 bioMérieux Main Business
5.6.3 bioMérieux Hepatitis B and C Diagnostics Products, Services and Solutions
5.6.4 bioMérieux Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 bioMérieux Recent Developments
5.7 Cepheid
5.7.1 Cepheid Profile
5.7.2 Cepheid Main Business
5.7.3 Cepheid Hepatitis B and C Diagnostics Products, Services and Solutions
5.7.4 Cepheid Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Cepheid Recent Developments
5.8 Chembio Diagnostics
5.8.1 Chembio Diagnostics Profile
5.8.2 Chembio Diagnostics Main Business
5.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
5.8.4 Chembio Diagnostics Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Chembio Diagnostics Recent Developments
5.9 DiaSorin
5.9.1 DiaSorin Profile
5.9.2 DiaSorin Main Business
5.9.3 DiaSorin Hepatitis B and C Diagnostics Products, Services and Solutions
5.9.4 DiaSorin Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 DiaSorin Recent Developments
5.10 Enzo Life Sciences
5.10.1 Enzo Life Sciences Profile
5.10.2 Enzo Life Sciences Main Business
5.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Products, Services and Solutions
5.10.4 Enzo Life Sciences Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Enzo Life Sciences Recent Developments
5.11 Hologic
5.11.1 Hologic Profile
5.11.2 Hologic Main Business
5.11.3 Hologic Hepatitis B and C Diagnostics Products, Services and Solutions
5.11.4 Hologic Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Hologic Recent Developments
5.12 MedMira
5.12.1 MedMira Profile
5.12.2 MedMira Main Business
5.12.3 MedMira Hepatitis B and C Diagnostics Products, Services and Solutions
5.12.4 MedMira Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 MedMira Recent Developments
5.13 OraSure Technologies
5.13.1 OraSure Technologies Profile
5.13.2 OraSure Technologies Main Business
5.13.3 OraSure Technologies Hepatitis B and C Diagnostics Products, Services and Solutions
5.13.4 OraSure Technologies Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 OraSure Technologies Recent Developments
5.14 Quest Diagnostics
5.14.1 Quest Diagnostics Profile
5.14.2 Quest Diagnostics Main Business
5.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
5.14.4 Quest Diagnostics Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Quest Diagnostics Recent Developments
5.15 Quidel Corp
5.15.1 Quidel Corp Profile
5.15.2 Quidel Corp Main Business
5.15.3 Quidel Corp Hepatitis B and C Diagnostics Products, Services and Solutions
5.15.4 Quidel Corp Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Quidel Corp Recent Developments
5.16 Randox Laboratories
5.16.1 Randox Laboratories Profile
5.16.2 Randox Laboratories Main Business
5.16.3 Randox Laboratories Hepatitis B and C Diagnostics Products, Services and Solutions
5.16.4 Randox Laboratories Hepatitis B and C Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Randox Laboratories Recent Developments
6 North America
6.1 North America Hepatitis B and C Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hepatitis B and C Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hepatitis B and C Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hepatitis B and C Diagnostics Market Dynamics
11.1 Hepatitis B and C Diagnostics Industry Trends
11.2 Hepatitis B and C Diagnostics Market Drivers
11.3 Hepatitis B and C Diagnostics Market Challenges
11.4 Hepatitis B and C Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables
Table 1. Global Market Hepatitis B and C Diagnostics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Hepatitis B and C Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Hepatitis B and C Diagnostics Market Size Share by Region (2018-2023)
Table 4. Global Hepatitis B and C Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Hepatitis B and C Diagnostics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Hepatitis B and C Diagnostics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Hepatitis B and C Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2024-2029)
Table 11. North America Hepatitis B and C Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Hepatitis B and C Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Hepatitis B and C Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Hepatitis B and C Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Hepatitis B and C Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Hepatitis B and C Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Hepatitis B and C Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Hepatitis B and C Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Hepatitis B and C Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Hepatitis B and C Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Hepatitis B and C Diagnostics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Hepatitis B and C Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2023)
Table 24. Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2024-2029)
Table 26. North America Hepatitis B and C Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Hepatitis B and C Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Hepatitis B and C Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Hepatitis B and C Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Hepatitis B and C Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Hepatitis B and C Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Hepatitis B and C Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Hepatitis B and C Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Hepatitis B and C Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Hepatitis B and C Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Hepatitis B and C Diagnostics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Hepatitis B and C Diagnostics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis B and C Diagnostics as of 2022)
Table 39. Date of Key Players Enter into Hepatitis B and C Diagnostics Market
Table 40. Global Hepatitis B and C Diagnostics Key Players Headquarters and Area Served
Table 41. Hepatitis B and C Diagnostics Product Solution and Service
Table 42. Global Hepatitis B and C Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Diagnostics Basic Information List
Table 45. Roche Diagnostics Description and Business Overview
Table 46. Roche Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Roche Diagnostics (2018-2023)
Table 48. Roche Diagnostics Recent Developments
Table 49. Abbott Basic Information List
Table 50. Abbott Description and Business Overview
Table 51. Abbott Hepatitis B and C Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Abbott (2018-2023)
Table 53. Abbott Recent Developments
Table 54. Siemens Basic Information List
Table 55. Siemens Description and Business Overview
Table 56. Siemens Hepatitis B and C Diagnostics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Siemens (2018-2023)
Table 58. Siemens Recent Developments
Table 59. Qiagen Basic Information List
Table 60. Qiagen Description and Business Overview
Table 61. Qiagen Hepatitis B and C Diagnostics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Qiagen (2018-2023)
Table 63. Qiagen Recent Developments
Table 64. Abbott Basic Information List
Table 65. Abbott Description and Business Overview
Table 66. Abbott Hepatitis B and C Diagnostics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Abbott (2018-2023)
Table 68. Abbott Recent Developments
Table 69. bioMérieux Basic Information List
Table 70. bioMérieux Description and Business Overview
Table 71. bioMérieux Hepatitis B and C Diagnostics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of bioMérieux (2018-2023)
Table 73. bioMérieux Recent Developments
Table 74. Cepheid Basic Information List
Table 75. Cepheid Description and Business Overview
Table 76. Cepheid Hepatitis B and C Diagnostics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Cepheid (2018-2023)
Table 78. Cepheid Recent Developments
Table 79. Chembio Diagnostics Basic Information List
Table 80. Chembio Diagnostics Description and Business Overview
Table 81. Chembio Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Chembio Diagnostics (2018-2023)
Table 83. Chembio Diagnostics Recent Developments
Table 84. DiaSorin Basic Information List
Table 85. DiaSorin Description and Business Overview
Table 86. DiaSorin Hepatitis B and C Diagnostics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of DiaSorin (2018-2023)
Table 88. DiaSorin Recent Developments
Table 89. Enzo Life Sciences Basic Information List
Table 90. Enzo Life Sciences Description and Business Overview
Table 91. Enzo Life Sciences Hepatitis B and C Diagnostics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Enzo Life Sciences (2018-2023)
Table 93. Enzo Life Sciences Recent Developments
Table 94. Hologic Basic Information List
Table 95. Hologic Description and Business Overview
Table 96. Hologic Hepatitis B and C Diagnostics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Hologic (2018-2023)
Table 98. Hologic Recent Developments
Table 99. MedMira Basic Information List
Table 100. MedMira Description and Business Overview
Table 101. MedMira Hepatitis B and C Diagnostics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of MedMira (2018-2023)
Table 103. MedMira Recent Developments
Table 104. OraSure Technologies Basic Information List
Table 105. OraSure Technologies Description and Business Overview
Table 106. OraSure Technologies Hepatitis B and C Diagnostics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of OraSure Technologies (2018-2023)
Table 108. OraSure Technologies Recent Developments
Table 109. Quest Diagnostics Basic Information List
Table 110. Quest Diagnostics Description and Business Overview
Table 111. Quest Diagnostics Hepatitis B and C Diagnostics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Quest Diagnostics (2018-2023)
Table 113. Quest Diagnostics Recent Developments
Table 114. Quidel Corp Basic Information List
Table 115. Quidel Corp Description and Business Overview
Table 116. Quidel Corp Hepatitis B and C Diagnostics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Quidel Corp (2018-2023)
Table 118. Quidel Corp Recent Developments
Table 119. Randox Laboratories Basic Information List
Table 120. Randox Laboratories Description and Business Overview
Table 121. Randox Laboratories Hepatitis B and C Diagnostics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Hepatitis B and C Diagnostics Business of Randox Laboratories (2018-2023)
Table 123. Randox Laboratories Recent Developments
Table 124. North America Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 125. North America Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 126. Europe Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 127. Europe Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 128. Asia-Pacific Hepatitis B and C Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 130. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 131. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2018-2023)
Table 132. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2024-2029)
Table 133. Latin America Hepatitis B and C Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 134. Latin America Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 135. Latin America Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 136. Middle East & Africa Hepatitis B and C Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 137. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 138. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 139. Hepatitis B and C Diagnostics Market Trends
Table 140. Hepatitis B and C Diagnostics Market Drivers
Table 141. Hepatitis B and C Diagnostics Market Challenges
Table 142. Hepatitis B and C Diagnostics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B and C Diagnostics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Hepatitis B and C Diagnostics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Hepatitis B and C Diagnostics Market Share by Regions: 2022 VS 2029
Figure 4. Global Hepatitis B and C Diagnostics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Hepatitis B and C Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Hepatitis B and C Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Hepatitis B and C Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Hepatitis B and C Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Hepatitis B and C Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Hepatitis B
Figure 11. Global Hepatitis B Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Hepatitis C
Figure 13. Global Hepatitis C Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Hepatitis B and C Diagnostics Market Size Share by Type: 2022 & 2029
Figure 15. North America Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2029)
Figure 16. Europe Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Share by Type (2018-2029)
Figure 20. Immunodiagnostics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Nucleic Acid Test (NAT) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global Hepatitis B and C Diagnostics Market Size Share by Application: 2022 & 2029
Figure 23. North America Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2029)
Figure 24. Europe Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2029)
Figure 26. Latin America Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Share by Application (2018-2029)
Figure 28. Hepatitis B and C Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Hepatitis B and C Diagnostics Market Share in 2022
Figure 30. North America Hepatitis B and C Diagnostics Market Share by Country (2018-2029)
Figure 31. U.S. Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 32. Canada Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 33. Germany Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 34. France Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 36. Italy Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 37. Russia Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2018-2029)
Figure 40. China Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 41. Japan Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 44. India Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 45. Australia Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America Hepatitis B and C Diagnostics Market Share by Country (2018-2029)
Figure 47. Mexico Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Country (2018-2029)
Figure 50. Turkey Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 52. UAE Hepatitis B and C Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report 
